Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Serum antibody immunoreactivity to equine zona protein after SpayVac vaccination.

Mask TA, Schoenecker KA, Kane AJ, Ransom JI, Bruemmer JE.

Theriogenology. 2015 Jul 15;84(2):261-7. doi: 10.1016/j.theriogenology.2015.03.012. Epub 2015 Mar 24.

PMID:
25922172
2.

Early versus later presentations of venous malformations: where and why?

Vogel SA, Hess CP, Dowd CF, Hoffman WY, Kane AJ, Rajaii R, Frieden IJ.

Pediatr Dermatol. 2013 Sep-Oct;30(5):534-40. doi: 10.1111/pde.12162. Epub 2013 May 16.

PMID:
23679583
3.

Modern surgical outcomes following surgery for sphenoid wing meningiomas.

Sughrue ME, Rutkowski MJ, Chen CJ, Shangari G, Kane AJ, Parsa AT, Berger MS, McDermott MW.

J Neurosurg. 2013 Jul;119(1):86-93. doi: 10.3171/2012.12.JNS11539. Epub 2013 Feb 22.

PMID:
23432379
4.

Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas.

Ivan ME, Cheng JS, Kaur G, Sughrue ME, Clark A, Kane AJ, Aranda D, McDermott M, Barani IJ, Parsa AT.

J Neurol Surg B Skull Base. 2012 Feb;73(1):76-83. doi: 10.1055/s-0032-1304562.

5.

The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma.

Kaur G, Kane AJ, Sughrue ME, Madden M, Oh MC, Sun MZ, Safaee M, El-Sayed I, Aghi M, McDermott MW, Berger MS, Parsa AT.

J Clin Neurosci. 2013 Feb;20(2):281-6. doi: 10.1016/j.jocn.2012.05.029. Epub 2012 Dec 21.

6.

MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.

Kaur G, Kane AJ, Sughrue ME, Oh M, Safaee M, Sun M, Tihan T, McDermott MW, Berger MS, Parsa AT.

J Clin Neurosci. 2013 Jan;20(1):89-93. doi: 10.1016/j.jocn.2012.05.025. Epub 2012 Nov 5.

7.

Frequency and etiology of unexplained bilateral hydronephrosis in patients with breast cancer: results of a longitudinal CT study.

Kane AJ, Wang ZJ, Qayyum A, Yeh BM, Webb EM, Coakley FV.

Clin Imaging. 2012 Jul-Aug;36(4):263-6. doi: 10.1016/j.clinimag.2011.10.001. Epub 2012 Jun 8.

PMID:
22726962
8.

Atypia predicting prognosis for intracranial extraventricular neurocytomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Lehil M, Fang S, Parsa AT.

J Neurosurg. 2012 Feb;116(2):349-54. doi: 10.3171/2011.9.JNS10783. Epub 2011 Nov 4.

PMID:
22054208
9.

The long-term postsurgical prognosis of patients with pineoblastoma.

Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, McClinton L, Barani IJ, Parsa AT.

Cancer. 2012 Jan 1;118(1):173-9. doi: 10.1002/cncr.26300. Epub 2011 Jun 29. Review.

10.

Clinical features and post-surgical outcome of patients with astroblastoma.

Sughrue ME, Choi J, Rutkowski MJ, Aranda D, Kane AJ, Barani IJ, Parsa AT.

J Clin Neurosci. 2011 Jun;18(6):750-4. doi: 10.1016/j.jocn.2010.11.007. Epub 2011 Apr 19. Review.

PMID:
21507653
11.

Clinical and surgical considerations for cerebellopontine angle meningiomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Berger MS, McDermott MW, Parsa AT.

J Clin Neurosci. 2011 Jun;18(6):755-9. doi: 10.1016/j.jocn.2010.09.023. Epub 2011 Apr 19.

PMID:
21507650
12.

Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.

Rutkowski MJ, Sughrue ME, Kane AJ, Kim JM, Bloch O, Parsa AT.

J Neurooncol. 2011 Nov;105(2):165-71. doi: 10.1007/s11060-011-0576-7. Epub 2011 Apr 19.

PMID:
21503828
13.

Anatomic location is a risk factor for atypical and malignant meningiomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, Berger MS, Parsa AT.

Cancer. 2011 Mar 15;117(6):1272-8. doi: 10.1002/cncr.25591. Epub 2010 Nov 8.

14.

Extent of resection and the long-term durability of vestibular schwannoma surgery.

Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Kaur G, Yang I, Pitts LH, Parsa AT.

J Neurosurg. 2011 May;114(5):1218-23. doi: 10.3171/2010.11.JNS10257. Epub 2011 Jan 21.

PMID:
21250800
15.

Implications of cystic features in vestibular schwannomas of patients undergoing microsurgical resection.

Jian BJ, Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Kaur G, Yang I, Pitts LH, Parsa AT.

Neurosurgery. 2011 Apr;68(4):874-80; discussion 879-80. doi: 10.1227/NEU.0b013e318208f614.

PMID:
21221029
16.

A critical evaluation of vestibular schwannoma surgery for patients younger than 40 years of age.

Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Yang I, Pitts LH, Parsa AT.

Neurosurgery. 2010 Dec;67(6):1646-53; discussion 1653-4. doi: 10.1227/NEU.0b013e3181f8d3d3.

PMID:
21107195
17.

The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients.

Barry JJ, Jian BJ, Sughrue ME, Kane AJ, Mills SA, Tihan T, Parsa AT.

Neurosurgery. 2011 Jan;68(1):231-40; discussion 240-1. doi: 10.1227/NEU.0b013e3181fd2ac5. Review.

PMID:
21099719
18.

Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction.

Soskin DP, Kane AJ, Stern TA.

Psychosomatics. 2010 Nov-Dec;51(6):532-5. doi: 10.1176/appi.psy.51.6.532.

PMID:
21051688
19.

A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors.

Ivan ME, Sughrue ME, Clark AJ, Kane AJ, Aranda D, Barani IJ, Parsa AT.

J Neurosurg. 2011 May;114(5):1299-305. doi: 10.3171/2010.9.JNS10699. Epub 2010 Oct 29.

PMID:
21029039
20.

The molecular pathology of central neurocytomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Tihan T, Parsa AT.

J Clin Neurosci. 2011 Jan;18(1):1-6. doi: 10.1016/j.jocn.2010.06.004. Epub 2010 Sep 29. Review.

PMID:
20884210
21.

Cancer and the complement cascade.

Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Parsa AT.

Mol Cancer Res. 2010 Nov;8(11):1453-65. doi: 10.1158/1541-7786.MCR-10-0225. Epub 2010 Sep 24. Review.

22.

Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays.

Sughrue ME, Rutkowski MJ, Kane AJ, Parsa AT.

J Clin Neurosci. 2010 Dec;17(12):1573-7. doi: 10.1016/j.jocn.2010.05.007. Epub 2010 Sep 9.

23.

EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.

Kane AJ, Sughrue ME, Rutkowski MJ, Phillips JJ, Parsa AT.

Neuroreport. 2010 Nov 17;21(16):1018-22. doi: 10.1097/WNR.0b013e32833f19f2.

24.

Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma.

Bloch O, Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, Yang I, Pitts LH, Parsa AT.

J Neurooncol. 2011 Apr;102(2):281-6. doi: 10.1007/s11060-010-0315-5. Epub 2010 Aug 6.

25.

Hearing preservation rates after microsurgical resection of vestibular schwannoma.

Sughrue ME, Yang I, Aranda D, Kane AJ, Parsa AT.

J Clin Neurosci. 2010 Sep;17(9):1126-9. doi: 10.1016/j.jocn.2010.01.018.

PMID:
20627586
26.

Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article.

Sughrue ME, Rutkowski MJ, Chang EF, Shangari G, Kane AJ, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2011 Mar;114(3):705-9. doi: 10.3171/2010.5.JNS091972. Epub 2010 Jun 25.

PMID:
20578801
27.

Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss.

Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Yang I, Pitts LH, Tihan T, Parsa AT.

J Neurosurg. 2011 Feb;114(2):386-93. doi: 10.3171/2010.5.JNS10256. Epub 2010 Jun 18.

PMID:
20560722
28.

Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Sughrue ME, Yang I, Kane AJ, Fang S, Clark AJ, Aranda D, Barani IJ, Parsa AT.

J Neurooncol. 2011 Feb;101(3):463-76. doi: 10.1007/s11060-010-0265-y. Epub 2010 Jun 10.

29.

The complement cascade as a mediator of tissue growth and regeneration.

Rutkowski MJ, Sughrue ME, Kane AJ, Ahn BJ, Fang S, Parsa AT.

Inflamm Res. 2010 Nov;59(11):897-905. doi: 10.1007/s00011-010-0220-6. Epub 2010 Jun 2. Review.

30.

A prospective study of hearing preservation in untreated vestibular schwannomas.

Sughrue ME, Kane AJ, Kaur R, Barry JJ, Rutkowski MJ, Pitts LH, Cheung SW, Parsa AT.

J Neurosurg. 2011 Feb;114(2):381-5. doi: 10.3171/2010.4.JNS091962. Epub 2010 May 21.

PMID:
20486891
31.

The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery.

Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, Yang I, Pitts LH, Parsa AT.

J Clin Neurosci. 2010 Jul;17(7):849-52. doi: 10.1016/j.jocn.2010.02.003. Epub 2010 May 14.

PMID:
20471836
32.

Factors influencing overall survival rates for patients with pineocytoma.

Clark AJ, Sughrue ME, Ivan ME, Aranda D, Rutkowski MJ, Kane AJ, Chang S, Parsa AT.

J Neurooncol. 2010 Nov;100(2):255-60. doi: 10.1007/s11060-010-0189-6. Epub 2010 May 12.

33.

Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma.

Sughrue ME, Kane AJ, Shangari G, Parsa AT, Berger MS, McDermott MW.

J Neurosurg. 2010 Nov;113(5):1115-21. doi: 10.3171/2010.3.JNS091975. Epub 2010 Apr 30.

PMID:
20433279
34.

Complement and the central nervous system: emerging roles in development, protection and regeneration.

Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Fang S, Parsa AT.

Immunol Cell Biol. 2010 Nov-Dec;88(8):781-6. doi: 10.1038/icb.2010.48. Epub 2010 Apr 20. Review.

PMID:
20404838
35.

The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas.

Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2010 Nov;113(5):1029-35. doi: 10.3171/2010.3.JNS091971. Epub 2010 Apr 9.

PMID:
20380529
36.

Predictors of mortality following treatment of intracranial hemangiopericytoma.

Rutkowski MJ, Sughrue ME, Kane AJ, Aranda D, Mills SA, Barani IJ, Parsa AT.

J Neurosurg. 2010 Aug;113(2):333-9. doi: 10.3171/2010.3.JNS091882. Review.

PMID:
20367074
37.

Posttreatment prognosis of patients with esthesioneuroblastoma.

Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani IJ, Parsa AT.

J Neurosurg. 2010 Aug;113(2):340-51. doi: 10.3171/2010.2.JNS091897. Review.

PMID:
20345216
38.

Tumor control after surgery and radiotherapy for pineocytoma.

Clark AJ, Ivan ME, Sughrue ME, Yang I, Aranda D, Han SJ, Kane AJ, Parsa AT.

J Neurosurg. 2010 Aug;113(2):319-24. doi: 10.3171/2009.12.JNS091683. Review.

PMID:
20136388
39.

Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma.

Sughrue ME, Yang I, Han SJ, Aranda D, Kane AJ, Amoils M, Smith ZA, Parsa AT.

Neurosurg Focus. 2009 Dec;27(6):E4. doi: 10.3171/2009.9.FOCUS09198. Review.

PMID:
19951057
40.

Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization.

Yeung AH, Sughrue ME, Kane AJ, Tihan T, Cheung SW, Parsa AT.

Neurosurg Focus. 2009 Dec;27(6):E2. doi: 10.3171/2009.9.FOCUS09185. Review.

PMID:
19951055
41.

Microsurgical hepatic artery reconstruction in paediatric liver transplantation.

Bade SA, Bayley GJ, Coren RA, Emmett JA, Fawcett J, Kane AJ, Vlynch S, Mcdermant GR, Richardson PW, Theile DR, Theile RJ.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1414-6.

PMID:
19950802
42.

Immunological considerations of modern animal models of malignant primary brain tumors.

Sughrue ME, Yang I, Kane AJ, Rutkowski MJ, Fang S, James CD, Parsa AT.

J Transl Med. 2009 Oct 8;7:84. doi: 10.1186/1479-5876-7-84. Review.

43.

Parietal activation during retrieval of abstract and concrete auditory information.

Klostermann EC, Kane AJM, Shimamura AP.

Neuroimage. 2008 Apr 1;40(2):896-901. doi: 10.1016/j.neuroimage.2007.10.068. Epub 2007 Dec 27.

44.

Invasion and metastasis markers in cancers.

Chin D, Boyle GM, Kane AJ, Theile DR, Hayward NK, Parson PG, Coman WB.

Br J Plast Surg. 2005 Jun;58(4):466-74. Review.

PMID:
15897029
45.

Radiographic changes in Thoroughbred yearlings. Part 2: Associations with racing performance.

Kane AJ, McIlwraith CW, Park RD, Rantanen NW, Morehead JP, Bramlage LR.

Equine Vet J. 2003 Jun;35(4):366-74.

PMID:
12880004
46.

Radiographic changes in Thoroughbred yearlings. Part 1: Prevalence at the time of the yearling sales.

Kane AJ, Park RD, McIlwraith CW, Rantanen NW, Morehead JP, Bramlage LR.

Equine Vet J. 2003 Jun;35(4):354-65.

PMID:
12880003
47.

Case-control study of factors associated with excessive proportions of early fetal losses associated with mare reproductive loss syndrome in central Kentucky during 2001.

Dwyer RM, Garber LP, Traub-Dargatz JL, Meade BJ, Powell D, Pavlick MP, Kane AJ.

J Am Vet Med Assoc. 2003 Mar 1;222(5):613-9.

PMID:
12619841
48.

Risk factors for and outcomes of noncatastrophic suspensory apparatus injury in Thoroughbred racehorses.

Hill AE, Stover SM, Gardner IA, Kane AJ, Whitcomb MB, Emerson AG.

J Am Vet Med Assoc. 2001 Apr 1;218(7):1136-44.

PMID:
11318366
49.

Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival.

Kane AJ, Barker JE, Mitchell GM, Theile DR, Romero R, Messina A, Wagh M, Fraulin FO, Morrison WA, Stewart AG.

Br J Pharmacol. 2001 Apr;132(8):1631-8.

50.

Beyond the case series: using regression analysis in modern veterinary medicine.

Morley PS, Kane AJ.

J Vet Intern Med. 1999 Mar-Apr;13(2):79-80. No abstract available.

Supplemental Content

Support Center